Nature

Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance

Detection of impending relapse in acute leukemias allows selection of patients for pre-emptive therapies that may avoid ultimate treatment failure but also the challenges of cytoreduction and ...
ascopubs.org

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study Patients with either MRD (≥1 ...
Nature

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Cure of acute myeloid leukemia (AML) is unlikely without achievement of complete remission (CR), including <5% bone marrow blasts by morphology and absence of circulating blasts or extramedullary ...
ascopubs.org

Residual ctDNA after treatment predicts early relapse in patients with early-stage NSCLC.

Racial disparities in lung adenocarcinoma: The contribution of African ancestry. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text ...